Rocket Lab Corp (RKLB) — Priced for transformation · Strong but decelerating · Improving structure, not yet profitable
Public reading · as of 2026-10-06 · educational, not investment advice
The short answer
Growth is strong but decelerating, margins are improving but still deeply negative, and the valuation prices a transformation the current cost structure has not yet delivered.
- Value: Priced for transformation (Medium confidence) — The stock trades at 57× revenue, meaning the market is valuing Rocket Lab as if it will become a much larger and far more profitable business than the numbers show today—betting…
- Growth: Strong but decelerating (High confidence) — Revenue is growing fast (38% year-over-year, up from $35M in 2020 to $769M now), but the pace has slowed from the multi-year average of 76%/year—still healthy expansion, yet no…
- Quality: Improving structure, not yet profitable (Medium confidence) — The company is getting better at turning revenue into gross profit (gross margin rose from negative to 37%), but it still burns cash heavily—losing $165M in net income and $316M…
Key figures
| Share price | $73.02 |
|---|---|
| Market cap | $43.69B |
| Revenue (TTM) | $769.15M |
| Net income (TTM) | $-165.46M |
| Revenue growth (YoY) | 38% |
| P/B | 12.5 |
| P/S | 56.8 |
| Return on equity | -4.7% |
| Return on capital employed | -6.1% |
| Net margin | -21.5% |
| Operating margin | -29.1% |
| Free cash flow margin | -41.1% |
| Debt / equity | 0 |
The full reading
What this company does
Rocket Lab is a space company that provides launch services to deliver spacecraft into orbit, and designs and manufactures spacecraft and spacecraft components. They operate launch vehicles called Electron and are developing a larger vehicle called Neutron, while also selling components like solar panels, reaction wheels, and star trackers to customers building satellites.
From the company’s latest 10-K · 2026-02-26, paraphrased.
Tap any ? to learn what it means and how it’s calculated.
Three-lens reading
Growth is strong but decelerating, margins are improving but still deeply negative, and the valuation prices a transformation the current cost structure has not yet delivered.
Priced for transformation
Is it cheap for what you get?
On balance, the P/S of 56.8 reflects a bet on a transformation story rather than current economics. The market is pricing the company not on today's negative margins and cash burn, but on the promise that the 100+ mission backlog converts at higher rates and the space-systems business drives margin expansion well beyond today's 37% gross margin.
Strong but decelerating
How fast and durably is it expanding?
On balance, the trajectory remains robust but shows clear deceleration. Revenue compounded at ~76%/yr over five years but has decelerated to 38% year-over-year, a natural moderation off a small base yet a meaningful slowdown. The 20-launch Synspective deal adds long-term visibility (missions scheduled 2028–2031), supporting the durability thesis, though the current 38% rate is less than half the historical CAGR.
Improving structure, not yet profitable
How profitable, sound and well-run is it?
On balance, the business shows structural improvement but remains a heavy cash consumer. Gross margin expanded from -34% in 2020 to 37% now, yet operating margin of -29% and FCF margin of -41% mean the cost base of $993M is still 1.3× revenue. ROCE improved from -39% in 2020 to -6% now, directionally consistent with the margin gains, but the business is not yet earning an adequate return on capital. Net cash of $2.4B (about 5% of market cap, or ~81 months of FCF burn at the as-of-date cash balance excluding any post-period financing) provides a cushion, and the backlog adds revenue visibility, but positive free cash flow has not been demonstrated.
💡Worth knowing▾
A P/S of 56.8 against 38% revenue growth and negative margins means the market is pricing Rocket Lab on a future state—backlog conversion, margin expansion, and sustained growth—rather than current economics.
The -41% FCF margin and -$316M annual burn mean the business consumes capital at scale; the $2.4B net cash provides a cushion, but sustained negative FCF forces a choice between slowing growth or raising dilutive capital.
ROCE improved from -39% to -6%, consistent with the gross-margin expansion, but the business is still not earning an adequate return on the capital base—the quality case depends on this trajectory continuing into positive territory.
The 100+ mission backlog through 2031 provides rare multi-year revenue visibility in aerospace, but it defers the growth proof—timing risk and conversion rates matter as much as the headline count.
The 20-mission Synspective deal lifts the backlog above 100 missions scheduled through 2031, providing multi-year revenue visibility in a capital-intensive industry where contracted demand is rare. Revenue has compounded at ~76%/yr over five years, gross margin has swung from -34% to 37%, and ROCE has improved from -39% to -6%, all indicating the launch and space-systems business model is working at scale. The $2.4B net cash position and minimal debt (debt/equity 0.01) eliminate near-term liquidity risk and fund the capex needed to deliver the backlog. If operating leverage materializes—the $993M cost base growing slower than revenue—the path to profitability is plausible, and the 57× P/S reflects the market pricing that scenario.
The company burns $316M in free cash flow annually, operating margin is -29%, and the cost base of $993M is 1.3× revenue, meaning breakeven requires ~29% revenue growth if costs hold—a strong assumption in a business scaling launch capacity and spacecraft systems. Revenue growth has decelerated sharply from a 76% five-year CAGR to 38% year-over-year, and the Synspective missions do not begin until 2028, leaving near-term growth dependent on converting the existing backlog without timing slippage. Stock-based comp of $82M (11% of revenue) is an ongoing dilution cost, and raising capital to cover the burn would be materially dilutive (a one-year-burn raise of $316M would issue ~4.3M shares, ~0.7% dilution). The 57× P/S prices a margin inflection and sustained high growth the current trends do not yet confirm—if the cost base scales with revenue or the backlog converts more slowly, the valuation has no support.
- Gross margin holds near 37% (now 37.3%) as the backlog converts and the space-systems business scales
- Operating leverage emerges: the $993M cost base does not scale 1:1 with revenue, allowing operating margin to move toward breakeven (now -29.1%)
- The 100+ mission backlog converts at rates that sustain revenue growth near the current 38% year-over-year pace
- Free cash flow improves materially from the current -$316M TTM as revenue scales and capex moderates
- Operating margin reaches zero or better (now -29%), demonstrating the cost base can be covered at this revenue scale
- Free cash flow turns positive on a sustained basis (now -$316M TTM), proving the business model generates cash rather than consuming it
- Revenue growth reaccelerates materially above the current 38% year-over-year, validating the backlog-conversion thesis and justifying the growth premium
- A large equity raise or sustained margin deterioration would signal the path to profitability is longer than the market prices
What to watch
| Signal | What to watch for | Where it stands |
|---|---|---|
| TailwindGrowth | ||
| Backlog conversion: the 100+ missions through 2031 must convert at rates that sustain revenue growth near 38% year-over-year and avoid timing slippage, particularly as the Synspective missions begin in 2028. | Quarterly revenue stays on a trajectory consistent with 30%+ annual growth | Backlog above 100 missions; Synspective alone is 47 missions Rocket Lab Launch Backlog Tops 100 After Synspective Deal ↗ |
| TailwindQuality | ||
| Gross margin trajectory: the swing from -34% in 2020 to 37% now is the foundation of the bull case; if margin stalls or reverses as the backlog mix shifts (more launch vs. space systems), the profitability path lengthens. | Gross margin holds above 35% as the backlog converts | Gross margin now 37.3%, up 71 points over five years; each margin point is worth ~$7.7M in gross profit |
| Watch-outQuality | ||
| Operating leverage: the $993M cost base must grow slower than revenue for operating margin to move toward breakeven; if costs scale 1:1 with revenue, the burn persists and the valuation thesis breaks. | Operating margin improves toward -15% or better | Operating cost base $993M, 1.3× revenue; operating margin -29.1%, needs ~29% revenue growth to break even if costs hold |
| Watch-outQuality | ||
| Cash consumption: FCF margin of -41% means the business consumes $316M annually; a material improvement (driven by margin expansion or lower capex) would reduce dilution risk and validate the model, while sustained burn forces a capital raise. | Free cash flow reaches -$150M or better annually | FCF -$316M TTM, -41% margin; net cash $2.4B provides ~81 months at the as-of-date burn; a one-year-burn raise would dilute ~0.7% |
The reading rests on the assumption that aerospace is a **scalable-software-style business**: that once Rocket Lab crosses a revenue threshold, its $993M cost base will grow much slower than revenue, delivering operating leverage and the margin inflection the 57× P/S prices.
The live debate is whether launch and spacecraft systems are instead **fundamentally capex- and variable-cost-intensive at every scale**—whether each new mission, each new satellite bus, each capacity expansion requires proportional engineering, manufacturing, and capital investment that keeps the cost base rising in step with revenue, as traditional aerospace has always done.
If the cost base scales with revenue, operating margin remains stuck near today's -29%, free cash flow stays deeply negative, the $2.4B net cash burns down over years, and the valuation has no anchor—the entire thesis that Rocket Lab will 'cross over' to profitability collapses, and the P/S of 57 prices a transformation that cannot happen within this business model.
This is a judgment about the nature of the aerospace industry in the 2020s—whether Rocket Lab's vertically integrated, reusable-launch-and-spacecraft model breaks the old capital intensity of the sector, or whether physics, supply chains, and talent costs mean aerospace will never give you software-
Research and education, not investment advice. AI-generated and may contain errors — verify against primary sources before relying on it; Navam Digital is not responsible for decisions made from this output. The reading is grounded in the facts below; you make the decision. Generated by Sonnet, with recent news.
Peers
suggested comparablesSuggested from sector and business model. Each ticker is verified against SEC filings.
Comparables are suggested by industry, business model, and available filings. They are not investment recommendations, and may differ in size, capital structure, or valuation.
- SPCXSPACE EXPLORATION TECHNOLOGIES CORP
- ASTSAST SpaceMobile, Inc.
- LUNRIntuitive Machines, Inc.
Recent news
8 headlinesRocket Lab’s most significant recent development was a record 20-launch Electron contract with Synspective, its largest commercial launch agreement to date, which lifts Synspective to 47 total booked missions and pushes Rocket Lab’s backlog above 100 missions. The company said the multi-year launches are scheduled from 2028 through 2031, strengthening its long-term commercial pipeline. The contract news was the main fresh item in the past week; no newer earnings release, guidance update, regulatory action, financing, M&A, or major management change emerged in the available coverage. Shares reacted higher after the announcement as investors focused on the larger backlog and the customer concentration win.
Recent coverage feeding the reading above. Links open the source.
- Rocket Lab Launch Backlog Tops 100 After Synspective Deal ↗
- Rocket Report: SpaceX completes launch triple-header ↗
- Latest News ↗
- Rocket Lab Stock Jumps After Massive 20-Mission Launch ... ↗
- Rocket Lab Climbs 5% as Largest-Ever Electron Deal Lifts Backlog Past 100 Missions; AST SpaceMobile Ticks Up, SpaceX Holds Flat ↗
- Rocket Lab signs contract with Synspective for 20 Electron ... ↗
- Rocket Lab stock jumps on 20-launch deal with Synspective ↗
- Rocket Lab Shares Rise 5.2% After Synspective Launch ... ↗
Company filings
1 in the last monthMaterial events filed with the SEC (Form 8-K) — disclosed by the company. Read alongside, not in place of, independent coverage.
Financials
Prices are end-of-day; fundamentals come from the company's latest SEC filings and each carries its own as-of date (shown per row), so they are not as current as the price. Tags: SEC straight from the filing, computed derived by ThreeLens from filed figures, market from a market-data feed.
Ratios — computed from filings + price
Trends — from filings
How the business has moved over time. Hover or tap a point for its exact value; tap a chart to expand it.
TTM = trailing twelve months — the last four quarters, kept current. Tap to learn more.
Sources
Compiled from 7 public sources — filings and recent news, not analyst opinion. Fundamentals are from SEC EDGAR; market data via Twelve Data.